Page last updated: 2024-11-05

trihexyphenidyl and Focal Neurologic Deficits

trihexyphenidyl has been researched along with Focal Neurologic Deficits in 3 studies

Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.

Research Excerpts

ExcerptRelevanceReference
" Hence we would advise that if for any reason anticholinergic drugs are to be withdrawn in patients receiving a stable dosage of levodopa this must be done slowly."2.64Levodopa in Parkinsonism: the effects of withdrawal of anticholinergic drugs. ( Hughes, RC; Polgar, JG; Walton, JN; Weightman, D, 1971)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Crane, GE1
Weintraub, MI1
Van Woert, MH1
Hughes, RC1
Polgar, JG1
Weightman, D1
Walton, JN1

Trials

1 trial available for trihexyphenidyl and Focal Neurologic Deficits

ArticleYear
Levodopa in Parkinsonism: the effects of withdrawal of anticholinergic drugs.
    British medical journal, 1971, May-29, Volume: 2, Issue:5760

    Topics: Dihydroxyphenylalanine; Drug Synergism; Drug Tolerance; Female; Humans; Male; Methods; Neurologic Ma

1971

Other Studies

2 other studies available for trihexyphenidyl and Focal Neurologic Deficits

ArticleYear
Rapid reversal of tardive dyskinesia.
    The American journal of psychiatry, 1973, Volume: 130, Issue:10

    Topics: Adult; Chlorpromazine; Dibenzoxepins; Female; Haloperidol; Humans; Movement Disorders; Neurologic Ma

1973
Reversal by levodopa of cholinergic hypersensitivity in Parkinson's disease.
    The New England journal of medicine, 1971, Feb-25, Volume: 284, Issue:8

    Topics: Brain; Dihydroxyphenylalanine; Dopamine; Drug Hypersensitivity; Female; Handwriting; Humans; Injecti

1971